{
    "title": "Amgen revenue falls slightly as Lilly COVID deal contributes less",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11698335/Amgen-revenue-falls-slightly-Lilly-COVID-deal-contributes-less.html",
    "date": "2023-01-31",
    "keywords": [
        "revenue",
        "amgen",
        "year",
        "deal",
        "antibody",
        "horizon",
        "covid19",
        "biotechnology",
        "company",
        "forecast",
        "acquisition",
        "blockbuster",
        "treatment",
        "jan",
        "inc",
        "tuesday",
        "fourthquarter",
        "increase",
        "quarter",
        "supply",
        "health",
        "authorization",
        "lillys",
        "covid",
        "november",
        "coronavirus",
        "companys",
        "manufacturing",
        "product",
        "jump",
        "drug",
        "record",
        "share",
        "analyst",
        "income",
        "impact",
        "portfolio",
        "access",
        "thyroid",
        "eye",
        "disease",
        "half",
        "opportunity",
        "growth",
        "executive",
        "robert",
        "bradway",
        "statement",
        "biosimilar",
        "arthritis",
        "europe",
        "october",
        "humira",
        "patent",
        "reporting",
        "roy",
        "bengaluru",
        "michael",
        "erman",
        "maplewood",
        "jersey",
        "editing",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}